Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Assessing the Time Demands of Cancer
Clinical trial update for NCT05708703 by the Masonic Cancer Center evaluating the time demands of cancer care in metastatic breast cancer an…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) [Phase 3]
A Phase 3 trial evaluating pembrolizumab followed by maintenance olaparib with first-line chemotherapy in BRCA non-mutated advanced epitheli…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study of ESG401 in Adults With Solid Tumors [Phase 1, Phase 2]
Clinical trial update on ESG401 in adults with solid tumors, spanning Phase 1 and Phase 2. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer [Phase 3]
Phase III study evaluating BD0801 in combination with chemotherapy for recurrent, platinum-resistant epithelial ovarian cancer has completed…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer . [Phase 2]
Phase 2 trial evaluating pembrolizumab with chemotherapy as neoadjuvant treatment for stage IV ovarian cancer has completed (status: COMPLET…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression
A clinical trial update evaluating the efficacy and safety of sacituzumab govitecan in patients with ovarian clear cell carcinoma after prog…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial [Phase 3]
Phase 3 randomized, placebo-controlled trial evaluating dietary fiber during radiotherapy in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating SYN818 in combination with olaparib for locally advanced or metastatic solid tumors is currently recruiting, includ…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. [Phase 1]
This ClinicalTrials.gov entry reports a completed Phase 1 study evaluating the safety, tolerability, and preliminary activity of trabectedin…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy
A completed clinical trial in gynecologic cancers evaluated taste alteration, sarcopenia, and malnutrition in patients treated with carbopla…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer [Phase 2]
Phase 2 trial of AL2846 capsules for advanced lung cancer and advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating outcomes after secondary cytoreductive surgery with or without carboplatin-based HIPEC, followed by systemic chemot…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
A Phase 1/2 study of TC-510 from TCR2 Therapeutics in mesothelin-expressing cancers is active but not recruiting, spanning multiple indicati…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Enhanced Assistance During Radiotherapy for Unmet Essential Needs [NA]
A completed clinical trial evaluated enhanced assistance during radiotherapy to address unmet essential needs across multiple cancer types.
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Sexual Health Integration in Treatment of Gynecological Oncology
Completed clinical trial evaluating integration of sexual health support and counseling into gynecologic oncology care. The study includes p…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors [Phase 1]
A Phase I trial evaluating intratumoral injection of GC001, an oncolytic vaccinia virus, in patients with advanced solid tumors is currently…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) [Phase 1, Phase 2]
Phase 1/2 trial results for GLIMMER-01, a bi-sialidase fusion protein from Palleon, tested across multiple solid tumors with results posted …
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers [Phase 1]
This clinical trial update summarizes the Phase 1 study of STRO-002, an anti-Folate Receptor Alpha antibody-drug conjugate, in ovarian and e…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for SNS-101 (anti-VISTA) as monotherapy and in combination with cemiplimab in adults with advanced solid tumors, cur…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial of FT538 for recurrent ovarian, fallopian tube, and primary peritoneal cancer has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
A post-marketing surveillance trial of olaparib (Lynparza) conducted by AstraZeneca has completed, reporting safety monitoring results acros…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a T-cell therapy in combination with nivolumab, relatlimab, and ipilimumab in metastatic ovarian cancer and rel…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours [Phase 1, Phase 2]
Cancer Research UK reported an ongoing Phase 1/2a trial of HMBD-001 in HER3-positive solid tumors; the study is currently Active Not Recruit…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients [NA]
A Mayo Clinic–sponsored clinical trial evaluating prehabilitation for patients with advanced ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers [Phase 1]
A Phase I trial of the radiopharmaceutical [177Lu]Lu-EVS459 in ovarian and lung cancer patients has been terminated.